Log in to save to my catalogue

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokine...

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokine...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c016e179215a4feb8bb8ff3b55ed3ebb

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

About this item

Full title

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2021-06, Vol.21 (1), p.1-719, Article 719

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background The aim of this study was to identify sources of variability including patient gender and body surface area (BSA) in pharmacokinetic (PK) exposure for high-dose methotrexate (MTX) continuous infusion in a large cohort of patients with hematological and solid malignancies. Methods We conducted a retrospective PK analysis of MTX plasma con...

Alternative Titles

Full title

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c016e179215a4feb8bb8ff3b55ed3ebb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c016e179215a4feb8bb8ff3b55ed3ebb

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-021-08443-x

How to access this item